Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
Crossref DOI link: https://doi.org/10.1186/2193-1801-3-342
Published Online: 2014-07-07
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mondello, Patrizia
Mian, Michael
Arrigo, Carmela
Pitini, Vincenzo
Text and Data Mining valid from 2014-07-07
Article History
Received: 6 May 2014
Accepted: 1 July 2014
First Online: 7 July 2014